HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/1/F48    most recent 00146.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (43) Citing Articles via Google Scholar Google Scholar Articles by Foster, R. R. Articles by Harper, S. J. Search for Related Content PubMed PubMed Citation Articles by Foster, R. R. Articles by Harper, S. J.

Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes

¹Microvascular Research Laboratories, Department of Physiology, University of Bristol, Preclinical Veterinary School, Bristol; and ²Children's and ³Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom

Submitted 22 April 2004 ; accepted in final form 18 August 2004

Vascular endothelial growth factor (VEGF) is anti-cytotoxic in podocytes. Moreover, it has been suggested that nephrin, a cell adhesion molecule of the podocyte slit diaphragm, can contribute to antiapoptotic mechanisms in these cells. We therefore investigated whether VEGF signals to reduce apoptosis and the role of nephrin in this survival mechanism. Flow cytometry showed that podocytes with nephrin mutations had a significantly greater proportion of apoptosis. Although VEGF reduced apoptosis in human conditionally immortalized podocytes [wild-type (WT)] by 18.1% of control (P < 0.001), it was unable to do so in nephrin-deficient human conditionally immortalized podocytes. Moreover, Western blotting and immunodetection with an anti-nephrin antibody showed that the phosphorylation of nephrin, compared with serum-starved WTs, was significantly increased (ratio of 3.36 ± 1.2 to control, P < 0.05) by VEGF treatment and significantly reduced by treatment with a neutralizing VEGF monoclonal antibody (mAb) (ratio of 0.2 ± 0.09 to control, P < 0.05). The AKT signaling pathway has been implicated in nephrin-mediated inhibition of apoptosis in transfected cells, but the role of this pathway has not previously been shown in podocytes. Surprisingly, exogenous VEGF decreased AKT/PKB phosphorylation in normal podocytes but increased it in nephrin-deficient podocytes. We suggest therefore that both exogenous and endogenous (podocyte derived) VEGF can stimulate the phosphorylation of nephrin and through this action may prevent podocyte apoptosis. However, the involvement of AKT in this survival response in normal human podocytes is not clear.

glomerular filtration rate; nephritis; VEGF; filtration; foot process

This article has been cited by other articles:

				J. Muller-Deile, K. Worthmann, M. Saleem, I. Tossidou, H. Haller, and M. Schiffer The balance of autocrine VEGF-A and VEGF-C determines podocyte survival Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1656 - F1667. [Abstract] [Full Text] [PDF]

				E. Favaro, I. Miceli, B. Bussolati, M. Schimitt-Ney, P. Cavallo Perin, G. Camussi, and M. M. Zanone Hyperglycemia Induces Apoptosis of Human Pancreatic Islet Endothelial Cells: Effects of Pravastatin on the Akt Survival Pathway Am. J. Pathol., August 1, 2008; 173(2): 442 - 450. [Abstract] [Full Text] [PDF]

				S. E. Quaggin and J. A. Kreidberg Development of the renal glomerulus: good neighbors and good fences Development, February 15, 2008; 135(4): 609 - 620. [Abstract] [Full Text] [PDF]

				D. E. Henao, P. W. Mathieson, M. A. Saleem, J. C. Bueno, and A. Cadavid A novel renal perspective of preeclampsia: a look from the podocyte Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1477 - 1477. [Full Text] [PDF]

				M. Albaqumi, T. J. Soos, L. Barisoni, and P. J. Nelson Collapsing Glomerulopathy J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2854 - 2863. [Abstract] [Full Text] [PDF]

				F. Guan, G. Villegas, J. Teichman, P. Mundel, and A. Tufro Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP Am J Physiol Renal Physiol, August 1, 2006; 291(2): F422 - F428. [Abstract] [Full Text] [PDF]

				R. R. Foster, S. C. Satchell, J. Seckley, M. S. Emmett, K. Joory, C. Y. Xing, M. A. Saleem, P. W. Mathieson, D. O. Bates, and S. J. Harper VEGF-C promotes survival in podocytes Am J Physiol Renal Physiol, July 1, 2006; 291(1): F196 - F207. [Abstract] [Full Text] [PDF]

				A. H. J. Salmon, C. R. Neal, D. O. Bates, and S. J. Harper Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli J. Physiol., January 1, 2006; 570(1): 141 - 156. [Abstract] [Full Text] [PDF]

				M. Nangaku, S. J. Shankland, and W. G. Couser Cellular Response to Injury in Membranous Nephropathy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204. [Abstract] [Full Text] [PDF]